GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Cash Ratio

Belluscura (FRA:9VQ) Cash Ratio : 2.05 (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Belluscura Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Belluscura's Cash Ratio for the quarter that ended in Jun. 2023 was 2.05.

Belluscura has a Cash Ratio of 2.05. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Belluscura's Cash Ratio or its related term are showing as below:

FRA:9VQ' s Cash Ratio Range Over the Past 10 Years
Min: 0.67   Med: 2.47   Max: 60.95
Current: 2.05

During the past 5 years, Belluscura's highest Cash Ratio was 60.95. The lowest was 0.67. And the median was 2.47.

FRA:9VQ's Cash Ratio is ranked better than
64.61% of 842 companies
in the Medical Devices & Instruments industry
Industry Median: 1.23 vs FRA:9VQ: 2.05

Belluscura Cash Ratio Historical Data

The historical data trend for Belluscura's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Cash Ratio Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Cash Ratio
2.11 2.68 2.26 14.65 0.67

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Cash Ratio Get a 7-Day Free Trial Premium Member Only 60.85 14.65 3.84 0.67 2.05

Competitive Comparison of Belluscura's Cash Ratio

For the Medical Devices subindustry, Belluscura's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Belluscura's Cash Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Belluscura's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Belluscura's Cash Ratio falls into.



Belluscura Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Belluscura's Cash Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash Ratio (A: Dec. 2022 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1.93/2.875
=0.67

Belluscura's Cash Ratio for the quarter that ended in Jun. 2023 is calculated as:

Cash Ratio (Q: Jun. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=3.53/1.723
=2.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Belluscura  (FRA:9VQ) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Belluscura Cash Ratio Related Terms

Thank you for viewing the detailed overview of Belluscura's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Belluscura (FRA:9VQ) Business Description

Traded in Other Exchanges
Address
15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines